Cover Image

PAPERBACK
$29.75



View/Hide Left Panel

Appendix A
Workshop Agenda

National Cancer Policy Forum

Workshop on Extending the Spectrum of

Precompetitive Collaboration in Oncology Research


The Keck Center of The National Academies

500 Fifth Street, NW, Room 100

Washington, DC 20001


DAY 1: TUESDAY, FEBRUARY 9, 2010

8:00 am

Registration and Continental BreakfastRegistration and Continental Breakfast

8:30 am

Welcome from National Cancer Policy Forum and Overview of the Workshop

John Wagner, M.D., Ph.D., Merck & Co., Inc., Workshop Chair

8:45 am

General Characterization of the Precompetitive Collaboration Environment

Session Chair: John Wagner, M.D., Ph.D., Merck & Co., Inc.

 

Open Innovation Networks Between Academia and Industry

Neal Cohen, M.D., M.P.H., M.S., University of California–San Francisco School of Medicine

 

Overview of Precompetitive Collaboration with Exemplar Models

Jill Altshuler, M.B.A., AltshulerGray



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 91
Appendix A Workshop Agenda National Cancer Policy Forum Workshop on Extending the Spectrum of Precompetitive Collaboration in Oncology Research The Keck Center of The National Academies 500 Fifth Street, NW, Room 100 Washington, DC 20001 DAy 1: TuESDAy, FEBRuARy 9, 2010 8:00 am Registration and Continental Breakfast 8:30 am Welcome from National Cancer Policy Forum and Overview of the Workshop John Wagner, M.D., Ph.D., Merck & Co., Inc., Workshop Chair 8:45 am General Characterization of the Precompetitive Collaboration Environment Session Chair: John Wagner, M.D., Ph.D., Merck & Co., Inc. Open Innovation Networks Between Academia and Industry Neal Cohen, M.D., M.P.H., M.S., University of California– San Francisco School of Medicine Overview of Precompetitive Collaboration with Exemplar Models Jill Altshuler, M.B.A., AltshulerGray 

OCR for page 91
 PRECOMPETITIVE COLLABORATION IN ONCOLOGY RESEARCH Open Access Integrative Bionetworks Stephen Friend, M.D., Ph.D., Sage Bionetworks PatientsLikeMe James Heywood Panel Discussion and Audience Polling: 0 Minutes 11:15 am Break 11:30 am Precompetitive Collaboration in Science Session Chair: John Wagner, M.D., Ph.D., Merck & Co., Inc. SEMATECH William Spencer, Ph.D. Science Commons Thinh Nguyen, J.D. Panel Discussion: 0 Minutes 12:30 pm Lunch 1:30 pm Precompetitive Collaboration in Biomedicine Session Chair: Stephen Friend, M.D., Ph.D., Sage Bionetworks The Biomarkers Consortium David Wholley, M. Phil., Foundation for the National Institutes of Health Critical Path Institute Raymond Woosley, M.D., Ph.D. Breakthrough Innovation Bernard Munos, M.B.A., Ph.D., Eli Lilly and Company Precompetitive Informatics Initiatives in Drug Discovery Bryn Williams-Jones, Pfizer

OCR for page 91
 APPENDIX A Panel Discussion: 0 Minutes 3:45 pm Break 4:00 pm Day 1 Concluding Thoughts Open-Source Science Karim R. Lakhani, Ph.D., M.S., Harvard Business School Discussion and Audience Polling: 0 minutes 5:00 pm Adjourn Day 1 DAy 2: WEDNESDAy, FEBRuARy 10, 2010 8:00 am Registration and Continental Breakfast 8:30 am Thoughts on Day 1 and Report Back from Dinner Discussion 8:45 am Precompetitive Collaboration in Oncology Session Chair: Stephen Eck, M.D., Ph.D., Eli Lilly and Company I-SPY  TRIAL Laura Esserman, M.D., M.B.A., UCSF Carol Franc Buck Breast Care Center The Cancer Genome Atlas Joseph Vockley, Ph.D., National Cancer Institute Merck, AstraZeneca Drug Combination Pearl Huang, Ph.D., Merck & Co., Inc. CEO Roundtable on Cancer’s Life Sciences Consortium Gregory Curt, M.D., AstraZeneca

OCR for page 91
 PRECOMPETITIVE COLLABORATION IN ONCOLOGY RESEARCH Imaging Studies Gary Kelloff, M.D., National Cancer Institute1 Panel Discussion: 0 Minutes 11:30 am Break—Pick up Boxed Lunches and Return for Final Session 11:45 am Lessons Learned and Future Directions for Precompetitive Collaboration in Oncology Session Chair: John Wagner, M.D., Ph.D., Merck & Co., Inc. Opening Remarks Mark McClellan, M.D., Ph.D., Brookings Institution’s Engelberg Center for Health Care Reform Panelists: Jill Altshuler, M.B.A., AltshulerGray Neal Cohen, M.D., M.P.H., M.S., University of California– San Francisco School of Medicine Stephen Eck, M.D., Ph.D., Eli Lilly and Company Mark McClellan, M.D., Ph.D., Brookings Institution’s Engelberg Center for Health Care Reform Raymond Woosley, M.D., Ph.D., Critical Path Institute 1:30 pm Adjourn Day 2 1 Due to the snowstorm, Dr. Kelloff was unable to present at the workshop. However, his presentation slides were included in the workshop briefing materials.